Novalgine (Metamizole Sodium)

Metamizole sodium works by inhibiting cyclooxygenase enzymes, leading to decreased prostaglandin production. This reduction dampens the pain signaling pathways and lowers the hypothalamic set‑point for temperature, thereby providing analgesic and antipyretic effects. The precise mechanisms are still being studied, but the COX inhibition is central to its action.

The dosage of Novalgine is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of pain or fever, and overall clinical condition. Physicians tailor the regimen to achieve optimal therapeutic effect while minimizing risk, and patients should follow the specific instructions provided on the prescription label.

Safety data for metamizole sodium in pregnancy and lactation are limited, and the product’s pregnancy category is not established. Healthcare providers generally weigh the potential benefits against unknown risks before prescribing it to pregnant or nursing women. Consultation with a physician is essential to make an informed decision.

To place an order, submit an enquiry on the Novalgine product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details—including any cold‑chain requirements—and assists with import documentation.

Novalgine (metamizole sodium) belongs to the non‑opioid analgesic class and offers rapid pain relief and fever reduction, similar to NSAIDs such as ibuprofen. Unlike many NSAIDs, metamizole has a lower incidence of gastrointestinal irritation but carries a unique risk of agranulocytosis. Choice of therapy depends on the patient’s risk profile, comorbidities, and the clinician’s judgment.

Novalgine should be stored at temperatures below 25 °C in its original packaging. Protect the product from moisture, direct sunlight, and extreme heat. Keep it out of reach of children and ensure the container is tightly closed after each use to maintain stability and potency.

Novalgine is administered orally. The tablet should be swallowed whole with a glass of water and may be taken with or without food, as directed by the prescriber. Patients should not crush, chew, or split the tablet unless explicitly instructed, to preserve its intended release characteristics.

The most serious adverse reactions linked to Novalgine include agranulocytosis, a potentially life‑threatening drop in white blood cells; severe allergic reactions such as anaphylaxis; and rare but serious skin conditions like Stevens‑Johnson syndrome. Prompt medical attention is required if symptoms such as unexplained fever, sore throat, rash, or breathing difficulty develop.

Novalgine should be avoided in individuals with known hypersensitivity to metamizole or any of its excipients, patients with existing severe bone‑marrow disorders, and those who have experienced agranulocytosis with prior metamizole exposure. Caution is also advised for patients with significant renal or hepatic impairment, and it should not be combined with other NSAIDs without medical supervision.